Market Research Logo

North America Exosome Diagnostic And Therapeutic Market Forecast 2019-2027

North America Exosome Diagnostic And Therapeutic Market Forecast 2019-2027

KEY FINDINGS

The exosome diagnostic and therapeutic market uptake have increased the most by the healthcare and research professionals since the diagnosis through the said reagents and instruments reveal rapid direction for almost accurate diagnosis of any respective diseases.

The global exosome diagnostic and therapeutic market by North America was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 27.53% during the forecast period of 2019-2027.

MARKET INSIGHTS

Rising incidence and prevalence of diseases coupled with the enlarging geriatric population are the major driving factors for the growth of the exosome diagnostic and therapeutic market in North America. The market in the region is characterized by the presence of a huge number of suppliers, vacillating from local to international suppliers. Due to the abundance of suppliers, buyers are majorly expected to switch from one to another supplier.

COMPETITIVE INSIGHTS

Qiagen N.V., MBL International Corporation, Thermo Fisher Scientific Inc., HansaBioMed Life Sciences Ltd. (acquired by Lonza), Capricor Therapeutics, Inc., Aethlon Medical, Inc., Nanosomix Inc., System Biosciences (SBI), BioCat GmbH, Exosome Diagnostics Inc., Malvern Instruments Ltd., EVOX Therapeutics Ltd., Sistemic Ltd., Codiak BioSciences, and Hitachi Chemical Diagnostics, Inc. are the key companies that are mentioned in the report.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top-down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Diagnostic Is The Majorly Used Application
3.2.2. Software Segment Is Anticipated To Grow At A Significant Rate
3.2.3. Cancer Institutes Hold The Largest Market Share In Terms Of End-user
4. Market Dynamics
4.1. Market Scope & Definition
4.2. Market Drivers
4.2.1. Increase In Pervasiveness Of Cancer
4.2.2. Rising Government And Non Government Initiatives
4.2.3. Advancement In Technology
4.3. Market Restraints
4.3.1. Challenges Faced In The Usage Of Exosome
4.3.2. Stringent Regulation
4.4. Market Opportunities
4.4.1. Increase In Adoption Of Innovative And Advanced Exosome Diagnostic And Therapeutic Procedures
4.5. Market Challenges
4.5.1. Low Awareness In The Developing Countries
5. Market By Application
5.1. Diagnostic
5.2. Therapeutic
6. Market By Product
6.1. Instrument
6.2. Reagent
6.3. Software
7. Market By End-user
7.1. Cancer Institute
7.2. Hospital
7.3. Diagnostic Center
7.4. Other End-user
8. Key Analytics
8.1. Porter’s Five Forces Model
8.1.1. Threat Of New Entrants
8.1.2. Threat Of Substitute
8.1.3. Bargaining Power Of Buyers
8.1.4. Bargaining Power Of Suppliers
8.1.5. Threat Of Competitive Rivalry
8.2. Exosome Etymology
8.3. Patent Analysis
8.4. Components Of Exosome
8.5. Opportunity Matrix
9. Geographical Analysis
9.1. North America
9.1.1. The United States
9.1.2. Canada
10. Competitive Landscape
10.1. Company Profiles
10.1.1. Aethlon Medical, Inc.
10.1.2. Biocat Gmbh
10.1.3. Capricor Therapeutics, Inc.
10.1.4. Codiak Biosciences
10.1.5. Evox Therapeutics Ltd.
10.1.6. Exosome Diagnostics Inc.
10.1.7. Hansabiomed Life Sciences Ltd. (Acquired By Lonza)
10.1.8. Hitachi Chemical Diagnostics, Inc.
10.1.9. Malvern Instruments Ltd.
10.1.10. Mbl International Corporation
10.1.11. Nanosomix Inc.
10.1.12. Sistemic Ltd.
10.1.13. System Biosciences (Sbi)
10.1.14. Thermo Fisher Scientific Inc.
10.1.15. Qiagen N.V.
Tables List
Table 1 Nomenclature Of Exosome Particles
Table 2 North America Exosome Diagnostic And Therapeutic Market 2019-2027 ($ Million)
Table 3 North America Exosome Diagnostic And Therapeutic Market By Application 2019-2027 ($ Million)
Table 4 North America Diagnostic Market 2019-2027 ($ Million)
Table 5 North America Therapeutic Market 2019-2027 ($ Million)
Table 6 North America Exosome Diagnostic And Therapeutic Market By Product 2019-2027 ($ Million)
Table 7 North America Instrument Market 2019-2027 ($ Million)
Table 8 Commercial Kits And Reagents Examples For The Isolation Of Exosome
Table 9 North America Reagent Market 2019-2027 ($ Million)
Table 10 North America Software Market 2019-2027 ($ Million)
Table 11 North America Exosome Diagnostic And Therapeutic Market By End-user 2019-2027 ($ Million)
Table 12 North America Cancer Institute Market 2019-2027 ($ Million)
Table 13 North America Hospital Market 2019-2027 ($ Million)
Table 14 Exosome Associated Protein In Clinical Diagnostics Usage
Table 15 North America Diagnostic Center Market 2019-2027 ($ Million)
Table 16 North America Other End-user Market 2019-2027 ($ Million)
Table 17 Type Of Proteins Found In Exosomes
Table 18 North America Exosome Diagnostic And Therapeutic Market By Country 2019-2027 ($ Million)
Figures List
Figure 1 North America Exosome Diagnostic And Therapeutic Market 2019-2027 ($ Million)
Figure 2 North America Exosome Diagnostic And Therapeutic Market Share By Application 2018 & 2027 (%)
Figure 3 North America Exosome Diagnostic And Therapeutic Market By Diagnostic 2019-2027 ($ Million)
Figure 4 North America Exosome Diagnostic And Therapeutic Market By Therapeutic 2019-2027 ($ Million)
Figure 5 North America Exosome Diagnostic And Therapeutic Market Share By Product 2018 & 2027 (%)
Figure 6 North America Exosome Diagnostic And Therapeutic Market By Instrument 2019-2027 ($ Million)
Figure 7 North America Exosome Diagnostic And Therapeutic Market By Reagent 2019-2027 ($ Million)
Figure 8 North America Exosome Diagnostic And Therapeutic Market By Software 2019-2027 ($ Million)
Figure 9 North America Exosome Diagnostic And Therapeutic Market Share By End-user 2018 & 2027 (%)
Figure 10 North America Exosome Diagnostic And Therapeutic Market By Cancer Institute 2019-2027 ($ Million)
Figure 11 North America Exosome Diagnostic And Therapeutic Market By Hospital 2019-2027 ($ Million)
Figure 12 North America Exosome Diagnostic And Therapeutic Market By Diagnostic Center 2019-2027 ($ Million)
Figure 13 Incidence Of Patients With Chronic Diseases North Americaly 2005-2030 (Millions)
Figure 14 North America Exosome Diagnostic And Therapeutic Market By Other End-user 2019-2027 ($ Million)
Figure 15 Porter’s Five Force Model
Figure 16 Number Of Papers Published On Exosome 2003-2017
Figure 17 The United States Exosome Diagnostic And Therapeutic Market 2019-2027 ($ Million)
Figure 18 Canada Exosome Diagnostic And Therapeutic Market 2019-2027 ($ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook